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Summary The aim of this study was to reveal the relationships between nutritional parameters
and pulmonary functions in patients with chronic obstructive pulmonary disease (COPD) in
both sexes. Spirometric, laboratory, and demographic data of 450 consecutive patients were
analysed retrospectively. Males had significantly greater pack-years of smoking, more severe
airway obstruction, and lower body mass index (BMI). In non-smokers, BMI was significantly
lower in men independent of age and pulmonary functions. Creatine kinase levels showed no
correlation with any pulmonary function parameters. Serum albumin levels correlated better
than BMI with pulmonary functions. In conclusion, females with COPD were maintained
weight better than men.
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Introduction
Body weight and body mass index (BMI) are independent
risk factors for mortality in chronic obstructive pulmonary
disease (COPD) patients [1,  2]. It is still unclear why
patients with COPD become undernourished as the disease
progress. We researched the relationships between possible
nutritional parameters (haemoglobin levels, serum albumin,
blood urea nitrogen, creatinine, cholesterol, triglycerides,
creatine kinase—a myocyte-derived enzyme) and lung
functions in COPD.
Materials and Methods
Spirometric, laboratory, and demographic data of 450
consecutive patients (348 men and 102 women), aged 39 to
84 years, were analysed retrospectively. All the patients had
COPD, according to the GOLD consensus report [3] and
chronic airflow limitation, defined as measured forced
expiratory volume in one second (FEV1)/forced vital
capacity (FVC)<70 percent. Exclusion criteria were
malignancy, tuberculosis, bronchiectasis, surgical operation
within 6 months, severe endocrine, hepatic, or renal disorders.
The best and technically acceptable spirometric data, height
and weight data, and smoking habits of each patient were
noted. Patients were considered to be underweight if their
BMI was <20 kg.m−2. FVC, FEV1, FEV1/FVC, maximum
mid-expiratory flow (MMEF), and peak expiratory flow rate
(PEF) levels were recorded as pulmonary function
parameters. All spirometric values obtained were related to a
reference value and expressed as a percentage of the
predicted value [4]. Serum albumin, blood urea nitrogen
(BUN), creatinine, cholesterol, triglycerides, creatine kinase,
haemoglobin levels and pulmonary function test results were
recorded when the patients were in a stable period. A non-
COPD group consisted of the patients who had not airway
obstruction (FEV1/FVC>70%).
All statistical analyses were performed with SPSS version
10.0 (SPSS Inc, Chicago, IL). Data were analysed using
independent-samples t test, and Pearson’s correlation test,
and Spearman Rank correlation test if the population was
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non-parametric. If correlation coefficient was less then 0.3,
the results were considered as non-significant. A 2-tailed p
value less than 0.05 was considered significant.
The study was approved by the Ethical Committee of the
School of Medicine, Cumhuriyet University (2005-2/2).
Results
All data are presented as means ± SE. The mean age years
of 102 females (22.7%) and 348 males (77.3%) were
62.9 ± 0.8 and 61.4 ± 0.5 respectively (p>0.05). A non-
COPD group, consisted of 103 males (77.4%) and 30
females, was gender- and age-matched. Demographic,
spirometric, and biochemical parameters of two groups were
presented in Table 1. The patients who had airway obstruction
had significantly greater pack-years of smoking, blood urea
nitrogen and serum creatinine levels but lower BMI.
When compared to female patients with COPD, males had
significantly greater pack-years of smoking, haemoglobin
levels, more severe airway obstruction but lower BMI
(Table 2). The prevalence of a BMI less than 20 kg.m−2 was
9.6% among the 450 outpatients studied, 13.9% in severe
COPD (FEV1<50% of reference) and 4.0% in mild to
moderate COPD. Only one of the women with severe
disease had BMI<20 kg.m−2.
There was a negative correlation between BMI and pack-
years of smoking in COPD (r: 0.24, p<0.01) but not in non-
COPD group. The decreasing effect of smoking on BMI
was valid only in COPD group (Odds ratio: 1.41, 95%
confidence intervals: 1.22-1.63). For the relationships
between BMI and pulmonary functions, the correlation
coefficients were 0.21 for FVC, 0.26 for FEV1, and 0.32 for
FEV1/FVC in COPD group.
In non-smokers, BMI was significantly lower in men
independent of age and pulmonary functions (Table 3). In the
entire COPD group (Table 4) and in non-smokers (Table 5),
BMI was not related any of pulmonary functions. However,
serum albumin showed a good correlation with pulmonary
functions. Multiple linear regression analysis revealed that
serum albumin level was the best predictor of FEV1
(beta = 12.307, p<0.001). Creatine kinase levels showed no
correlation any of the pulmonary function parameters (data
not shown).
Discussion
Table 1 showed that the patients with COPD had
significantly greater pack-years of smoking but lower BMI.
The relationship between BMI and smoking was restricted
only in COPD group. This finding suggests that the lower
BMI is due to the loss of lung functions. The higher correlation
coefficients between BMI and lung functions than those
between BMI and smoking also support this idea. Table 2
demonstrated that males had more severe loss of pulmonary
parenchyma because they had greater load of smoking than
females. Consequently, the males had lower BMI than those
of women.
Serum albumin level decreased with declining in pulmonary
function in our study. Schols et al. [5] reported that serum
albumin levels are positively associated with exercise







Age 61.9 ± 0.4 60.9 ± 0.7 0.28
FVC (%) 69.3 ± 1.0 88.7 ± 1.3 <0.01
FEV1 (%) 48.9 ± 0.9 96.0 ± 1.4 <0.01
FEV1/FVC (%) 55.3 ± 0.4 78.7 ± 0.6 <0.01
MMEF (%) 21.9 ± 0.5 89.3 ± 2.7 <0.01
PEF (%) 39.2 ± 0.7 85.3 ± 1.7 <0.01
BMI (kg.m−2) 26.1 ± 0.2 28.5 ± 0.4 <0.01
Haemoglobin (g.dL−1) 14.8 ± 0.1 15.0 ± 0.2 0.29
Serum albumin (g.L−1) 37.7 ± 0.4 38.2 ± 0.6 0.46
Blood urea nitrogen (mg/dl) 21.9 ± 0.9 16.9 ± 0.6 <0.01
Serum creatinine (mg/dl) 1.33 ± 0.03 1.00 ± 0.03 <0.01
Serum creatine kinase (U/L) 77.2 ± 4.0 96.4 ± 9.3 0.06
Serum cholesterol (mg/dl) 174.5 ± 7.7 179.9 ± 6.3 0.59
Serum triglycerides (mg/dl) 136.7 ± 12.1 121.0 ± 7.3 0.27
Smoking history (Pack-years) 33.4 ± 2.2 23.3 ± 3.2 0.01
FVC: forced vital capacity, FEV1: forced expiratory volume in one second, MMEF: maximum
mid-expiratory flow, PEF: peak expiratory flow, BMI: body mass indexGender Effect on Malnutrition in COPD
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performance, Katsura et al. [ 6] found that low serum
albumin can be a risk factor for poor outcome in COPD. We
found that serum albumin levels correlated better with
pulmonary functions than BMI. This finding suggests that
systemic catabolic process in COPD affects serum albumin
concentration more than BMI. Additionally, Table 3 showed
that BMI was significantly lower in male than in female in
non-smokers subset. Males were more susceptible to weight
loss and protein degradation despite the anabolic effects of
testosterone. One explanation for these findings is ethnicity.
For example, German women had a lower BMI than Turkish
ones [7]. Other explanation can be higher leptin levels in
women [8]. Another explanation is the different aetiology of
COPD. In our study, females had a history of tobacco use of
less than 5.5 pack-years. However, the minimum requirement
Table 2. Comparison of pulmonary functions and nutritional parameters in two genders
Parameters Males n = 348 Females n = 102 p level
FVC (%) 70.0 ± 1.1 77.8 ± 2.2 <0.01
FEV1 (%) 46.8 ± 1.0 56.9 ± 1.8 <0.01
FEV1/FVC (%) 54.2 ± 0.5 59.7 ± 0.7 <0.01
MMEF (%) 22.0 ± 0.6 22.1 ± 0.9 0.92
PEF (%) 38.9 ± 0.9 41.2 ± 1.4 0.17
BMI (kg.m−2) 24.8 ± 0.2 30.5 ± 0.6 <0.01
Haemoglobin (g.dL−1) 15.0 ± 0.2 13.9 ± 0.3 <0.01
Serum albumin (g.L−1) 37.3 ± 0.4 37.8 ± 0.7 0.52
Blood urea nitrogen (mg/dl) 22.6 ± 1.0 19.7 ± 1.3 0.09
Serum creatinine (mg/dl) 1.33 ± 0.03 1.31 ± 0.02 0.88
Serum creatine kinase (U/L) 79.7 ± 5.5 66.1 ± 5.8 0.09
Serum cholesterol (mg/dl) 167.6 ± 8.8 187.5 ± 14.9 0.26
Serum triglycerides (mg/dl) 127.3 ± 11.4 154.3 ± 27.5 0.38
Smoking history (Pack-years) 40.5 ± 2.3 5.3 ± 3.2 <0.01
FVC: forced vital capacity, FEV1: forced expiratory volume in one second, MMEF: maximum
mid-expiratory flow, PEF: peak expiratory flow, BMI: body mass index
Table 3. Nutritional markers and pulmonary functions in non-
smoker patients with COPD
Parameters Males (n = 24) Females (n = 41)
Age (years) 60.6 ± 2.2 63.3 ± 1.4
FVC (%) 65.8 ± 4.4 71.1 ± 3.5
FEV1 (%) 47.4 ± 3.5 49.9 ± 2.9
FEV1/FVC (%) 57.2 ± 1.9 57.3 ± 1.2
MMEF (%) 23.1 ± 2.5 18.9 ± 1.4
PEF (%) 40.6 ± 3.4 37.0 ± 2.0
BMI (kg.m−2) 25.7 ± 0.7 30.1 ± 0.9*
Haemoglobin (g.dL−1) 15.1 ± 0.3 13.9 ± 0.6
Serum albumin (g.L−1) 39.8 ± 0.9 37.7 ± 0.8
Blood urea nitrogen (mg/dl) 18.3 ± 1.4 22.0 ± 2.0
Serum creatinine (mg/dl) 1.22 ± 0.09 1.52 ± 0.03
Serum creatine kinase (U/L) 80.9 ± 11.4 66.2 ± 6.2
Serum cholesterol (mg/dl) 171.5 ± 5.5 177.2 ± 27.9
Serum triglycerides (mg/dl) 129.5 ± 8.5 109.9 ± 16.5
*p<0.01
FVC: forced vital capacity, FEV1: forced expiratory volume in
one second, MMEF: maximum mid-expiratory flow, PEF: peak
expiratory flow, BMI: body mass index
Table 4. Correlation coefficients between nutritional markers and














Males — 0.38 0.38 0.38 0.37
Females — — — — 0.38
FVC: forced vital capacity, FEV1: forced expiratory volume in
one second, MMEF: maximum mid-expiratory flow, PEF: peak
expiratory flow
Table 5. Correlation coefficients between nutritional markers















Males 0.54 0.49 — — 0.51
Females — 0.36 0.44 0.37 r: 0.39
FVC: forced vital capacity, FEV1: forced expiratory volume in
one second, MMEF: maximum mid-expiratory flow, PEF: peak
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is 10 pack-years for the development of COPD in most
clinical trials [9]. Ekici et al. [10] demonstrated that biomass
fuel exposure could cause chronic airway obstruction in our
region. Possibly COPD due to biomass exposure can lead to
different systemic effects than tobacco-induced COPD. This
result, however, await confirmation in a large prospective
study.
The effect of malnutrition on pulmonary function is
mediated in part by its effect on respiratory muscles. Arora
and Rochester [11] showed that nutritional depletion
reduced respiratory muscle strength in patients without lung
disease. On the other hand, skeletal muscle weakness is
frequently observed in patients with COPD, and is associated
with wasting of extremity fat-free mass [12]. Depletion of
fat-free mass, indicating loss of muscle mass, plays a pivotal
role in exercise tolerance [13]. In this study, we assessed
serum creatine kinase levels to evaluate myocyte dysfunction.
However, we did not find a correlation between this muscle-
derived parameter and pulmonary functions because serum
creatine kinase is not a specific marker for malnutrition.
In conclusion, nutritional depletion is associated with
impaired pulmonary functions in COPD. When compared to
controls, rising levels of BUN and serum creatinine suggest
a protein catabolism in patients with COPD. This catabolic
process appeared to be active only in male patients. Serum
albumin concentration is more accurate parameter than BMI
for assessing pulmonary dysfunction due to catabolic process
in COPD. Weight maintenance in females may be due to a
different aetiology of COPD.
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